NFKB1 and COVID-19: The increase in the level of the NFκB subunit, i.e., p52 protein, observed in this study in patients with the fatal form of COVID-19 may suggest that it is caused by oxidative stress and the expression of cytokines, including IL-6, which stimulates inflammatory processes.